We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Many of the top-selling biologic drug products will soon come off-patent. As a result, according to IMS, the biosimilar market is expected to reach between US$1.9-2.6 billion by 2015.
A biosimilar is a biological drug product that is similar to a previously approved brand name biologic. Typically, the differences are found in clinically inactive components, which result in little or no difference between the biosimilar and the approved biological product currently on the market in terms of safety, purity and efficacy. Many companies are activity working to develop and commercialize biosimilars.
One of the ways companies developing biosimilars will differentiate new products in similar therapeutic categories is to change the injection format and method of delivery. For many companies, the decision to select a prefilled syringe system rather than a branded vial format is strategic because it meets the demands of physicians and patients looking for easier modes of administration. Also, the syringe can be supplied in an auto-injector format for self-injection convenience.
Proper selection of plunger component materials in a ready-to-use format is critical to drug performance in a prefilled syringe. FluroTec closure technology, which is available for modern elastomer formulations for stoppers and plungers, is the leading choice of barrier film for components used with biologic drug products. FluroTec film provides an effective barrier against organic and inorganic extractables, minimizing interaction between the drug and the plunger. The fluorocarbon film also reduces absorption and adsorption of biologics, an important benefit for maintaining the safety and purity of products during shelf life.
Historically, the market has used gamma-sterilized plungers for syringe systems and steam-sterilized stoppers for vial systems. Selecting a steam-sterilized plunger can lower risks for biosimilars intended for a prefilled syringe format. Using a steam-sterilized plunger with FluroTec barrier film against an equivalent elastomer formulation used for vial stoppers can significantly reduce risks associated with extractable and leachable profiles, provide higher assurance for successful long-term stability to meet shelf-life requirements and can be leveraged in drug approvals since the materials are market proven and well recognized by regulatory agencies.
For biosimilar manufacturers, speed to market is key to gaining a strong market share, so a decision to match component technology to proven vial formats may be less risky. West offers several steam-sterilized plunger products, including Westar® ready-to-useplungers and our primary recommendation, NovaPure® ready-to-use plungers. Selection of these components early in the development process may move a biosimilar to market faster while ensuring that the drug product’s safety and efficacy is not affected by the change in packaging materials or sterilization modes.
FluroTec®, NovaPure® and Westar® are registered trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
FluroTec technology is licensed from Daikyo Seiko Ltd.
Recently, our Dublin, Ireland facility won the 2017 “Green Pharmaceutical Award” – a long-standing benchmark of excellence for those demonstrating best green practices in Ireland. Winners were announced at the Green Awards ceremony on February 21, 2017.
Coring, fragmentation, and stopper push-in are some of the common issues associated with rubber stoppers used with transfer devices (e.g., vial adapters). This is because they are punctured with spikes, which are significantly larger in diameter than needles, and are made from plastic materials.
On November 14, World Diabetes Day will be observed around the globe. Diabetes is a growing issue, with more than 415 million adults living with the disease, a number that is expected to increase to 642 million – or 1 in 10 adults – by 2040.
Supporting the health and well-being of our team members across the world is very important to us at West. Well-being often refers to happiness, quality of life, thriving and flourishing. Well-being can be described as the way you feel, the way you function and how you judge your life. It’s also a consideration of the “whole person.”
This spring, West team members in Jersey Shore, PA hosted an annual raffle featuring some outstanding prizes in support of Camp Victory, a camp designed especially for children with special needs. Children who live with chronic health problems, physical or mental disabilities, or the aftermath of catastrophic illness, know lifelong challenges. Camp Victory was built for these children. West’s Jersey Shore team has supported the important mission at Camp Victory through their West without Borders employee-led fundraising campaign for more than 40 years.<br />
English
Chinese
